Previous 10 | Next 10 |
home / stock / karbf / karbf news
HUDDINGE, Sweden , Nov. 27, 2019 /PRNewswire/ -- As previously communicated, Karo Pharma Aktiebolag (" Karo Pharma ") voluntarily and within a certain time undertook to divest Hydrokortison Trimb and all intellectual property rights and assets relating thereto, including necessary license...
HUDDINGE, Sweden , Nov. 20, 2019 /PRNewswire/ -- On November 5, 2019 , Karo Pharma Aktiebolag ("Karo Pharma") issued a press release regarding the Pfizer collaboration and license agreement related to ROR-gamma ("the Pfizer agreement"). The press release informed of Pfizer's decision to ...
STOCKHOLM , Sept. 4, 2019 /PRNewswire/ -- Karo Pharma Aktiebolag (the " Company " or " Karo Pharma ") today announces that the acquisition of all the shares of Trimb Holding AB (" Trimb ") from Avista Capital Partners (" Avista ") and other shareholders for MSEK 3,400 (the " Transaction "...
HUDDINGE, Sweden , Aug. 28, 2019 /PRNewswire/ -- The shareholders of Karo Pharma Aktiebolag, reg. no 556309-3359, are given notice of an Extraordinary General Meeting, to be held on Friday 20 September 2019 at 14:00 CET at Näringslivets Hus, Storgatan 19, Stockholm . Rig...
HUDDINGE, Sweden , July 19, 2019 /PRNewswire/ -- Karo Pharma Aktiebolag (" Karo Pharma ") today published its interim report for the period January - June 2019 . On page 2 of the Swedish language version of the interim report, it was, slightly misleadingly, stated that a directed rights ...
HUDDINGE, Sweden , July 19, 2019 /PRNewswire/ -- The Period And The Second Quarter Net sales amounted to MSEK 808.2 (756.5), whereof the second quarter MSEK 387.4 (489.4). This corresponds to an increase for the period of 7% and a decrease for the quarter of 21%. Excluding one-off i...
HUDDINGE, Sweden , April 26, 2019 /PRNewswire/ -- Net sales amounted to MSEK 420.8 (267.1). This corresponds to an increase of 58%. The growth is attributable to products acquired during the period. Net sales decreased by 6% compared to pro forma numbers for the same period 2018. At ...
HUDDINGE, Sweden , April 16, 2019 /PRNewswire/ -- The shareholders of Karo Pharma Aktiebolag, reg. no. 556309-3359, are given notice of the annual general meeting to be held at 14:00 CET on 16 May 2019 , at Näringslivets Hus, Storgatan 19 in Stockholm . Right to participat...
HUDDINGE, Sweden , April 3, 2019 /PRNewswire/ -- The Board of Karo Pharma Aktiebolag (publ) (" Karo Pharma ") has appointed Christoffer Lorenzen as the new CEO of Karo Pharma, replacing Peter Blom . Christoffer will take on his new position on July 1, 2019 . Up until this date, and ef...
HUDDINGE, Sweden , Feb. 14, 2019 FULL YEAR AND THE FOURTH QUARTER Net sales amounted to MSEK 1,615.1 (657.6), of which the fourth quarter amounted to MSEK 463.3 (238.7). This corresponds to an increase of 146% for the full year, and 94% for the fourth quarter. A large part of the gro...
News, Short Squeeze, Breakout and More Instantly...
Karo Pharma Aktiebolag Company Name:
KARBF Stock Symbol:
OTCMKTS Market:
HUDDINGE, Sweden , July 21, 2020 /PRNewswire/ -- Q2, April - June Net sales amounted to MSEK 688.9 (387.4). This corresponds to an increase of 78% for the period. The organic growth during the second quarter was -10%, currency impact 0% and 88% relates to the acquisition of ...
HUDDINGE, Sweden , May 26, 2020 /PRNewswire/ -- At today's annual general meeting of Karo Pharma, the following decisions were passed. The annual general meeting resolved to adopt the income statement and balance sheet for the group and the parent company. The annual general meeting res...
HUDDINGE, Sweden , May 8, 2020 /PRNewswire/ -- Karo Pharma Aktiebolag ("Karo Pharma") today announces the signing and closing of the acquisition of the remaining European rights to the Pevaryl ® brand portfolio from Cilag GmbH International, one of the Janssen Pharmaceutical C...